{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:14Z","timestamp":1792184654527,"version":"4.4.0"},"reference-count":127,"publisher":"Cambridge University Press (CUP)","issue":"S1","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"unspecified","delay-in-days":4116,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2003,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>What is the best approach for treating patients with social phobia (social anxiety disorder) over the long term? Social phobia is the most common anxiety disorder, with reported prevalence rates of up to 18.7%. Social phobia is characterized by a marked and persistent fear of being observed or evaluated by others in social performance or interaction situations and is associated with physical, cognitive, and behavioral (ie, avoidance) symptoms. The onset of social phobia typically occurs in childhood or adolescence and the clinical course, if left untreated, is usually chronic, unremitting, and associated with significant functional impairment. Social phobia exhibits a high degree of comorbidity with other psychiatric disorders, including mood disorders, anxiety disorders, and substance abuse\/dependence. Few people with social phobia seek professional help despite the existence of beneficial treatment approaches. The efficacy, tolerability, and safety of the selective serotonin reuptake inhibitors (SSRIs), evidenced in randomized clinical trials, support these agents as first-line treatment. The benzodiazepine clonazepam and certain monoamine oxidase inhibitors (representing both reversible and nonreversible inhibitors) may also be of benefit. Treatment of social phobia may need to be continued for several months to consolidate response and achieve full remission. The SSRIs have shown benefit in longterm treatment trials, while long-term treatment data from clinical studies of clonazepam are limited but support the drug's efficacy. There is also evidence for the effectiveness of exposure-based strategies of cognitive-behavioral therapy, and controlled studies suggest that the effects of treatment are generally maintained at long-term follow-up. In light of the chronicity and disability associated with social phobia, as well as the high relapse rate after short-term therapy, it is recommended that effective treatment be continued for at least 12 months.<\/jats:p>","DOI":"10.1017\/s1092852900006933","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T03:27:07Z","timestamp":1470108427000},"page":"40-52","source":"Crossref","is-referenced-by-count":38,"title":["WCA Recommendations for the Long-Term Treatment of Social Phobia"],"prefix":"10.1017","volume":"8","author":[{"given":"Michael","family":"Van Ameringen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Allgulander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borwin","family":"Bandelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Greist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Okasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Swinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"S1092852900006933_ref127","first-page":"29","article-title":"Clinical guidelines for establishing remission in patients with depression and anxiety","volume":"60","author":"Ballenger","year":"1999","journal-title":"J Ciin Psychiatry"},{"key":"S1092852900006933_ref126","first-page":"400","article-title":"Guidelines for the treatment of anxiety disorders in adults","volume":"55","author":"Dandrifosse","year":"2000","journal-title":"Rev Med Liege"},{"key":"S1092852900006933_ref125","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-6185(00)00027-X"},{"key":"S1092852900006933_ref124","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.4.312"},{"key":"S1092852900006933_ref123","doi-asserted-by":"publisher","DOI":"10.1159\/000012382"},{"key":"S1092852900006933_ref121","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.52.4.642"},{"key":"S1092852900006933_ref120","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(95)00013-N"},{"key":"S1092852900006933_ref118","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/17.2.114"},{"key":"S1092852900006933_ref117","first-page":"36","article-title":"Current status of psychotherapeutic interventions for social phobia","volume":"62","author":"Heimberg","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref116","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.0.CO;2-5"},{"key":"S1092852900006933_ref114","first-page":"S227","article-title":"Short-term efficacy of paroxetine in social anxiety disorder is maintained after long-term treatment","volume":"3","author":"Hair","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"S1092852900006933_ref112","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)80439-3"},{"key":"S1092852900006933_ref108","first-page":"180","article-title":"The treatment of social phobia","volume":"169","author":"Falloon","year":"1981","journal-title":"J New Merit Dis"},{"key":"S1092852900006933_ref009","first-page":"S290","article-title":"A functional neuroimaging study of social anxiety and its treatment","volume":"3","author":"Kilts","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"S1092852900006933_ref070","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.179.1.23"},{"key":"S1092852900006933_ref003","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291798008174"},{"key":"S1092852900006933_ref106","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)80096-6"},{"key":"S1092852900006933_ref077","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1997.7.17"},{"key":"S1092852900006933_ref044","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)80097-8"},{"key":"S1092852900006933_ref042","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.1999"},{"key":"S1092852900006933_ref079","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200008002-00004"},{"key":"S1092852900006933_ref099","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199810000-00004"},{"key":"S1092852900006933_ref102","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199907000-00006"},{"key":"S1092852900006933_ref095","first-page":"252","article-title":"Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol","volume":"49","author":"Liebowitz","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref107","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.62.2.350"},{"key":"S1092852900006933_ref004","first-page":"11","article-title":"Social anxiety disorder: an unrecognized problem in primary care","volume":"62","author":"Katzelnick","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref026","first-page":"S289","article-title":"Pharmacological dissection of panic disorder and social phobia: using valproic acid as a clinical tool","volume":"3","author":"Kinrys","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"S1092852900006933_ref001","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.11.1046"},{"key":"S1092852900006933_ref098","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199312000-00008"},{"key":"S1092852900006933_ref035","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950010008002"},{"key":"S1092852900006933_ref057","first-page":"48","article-title":"The Brief Social Phobia Scale","volume":"52","author":"Davidson","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref058","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291796004217"},{"key":"S1092852900006933_ref039","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70254-9"},{"key":"S1092852900006933_ref002","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291799008375"},{"key":"S1092852900006933_ref093","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198604000-00006"},{"key":"S1092852900006933_ref028","first-page":"4","article-title":"The history, epidemiology, and differential diagnosis of social anxiety disorder","volume":"60","author":"Moutier","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref122","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.56.2.251"},{"key":"S1092852900006933_ref111","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199908000-00010"},{"key":"S1092852900006933_ref050","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.3.457"},{"key":"S1092852900006933_ref094","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810340070009"},{"key":"S1092852900006933_ref091","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059030-00007"},{"key":"S1092852900006933_ref081","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.161.3.353"},{"key":"S1092852900006933_ref092","first-page":"610","article-title":"Psychopharmacological treatment of social phobia","volume":"21","author":"Liebowitz","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"S1092852900006933_ref041","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.1.90"},{"key":"S1092852900006933_ref100","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199612000-00003"},{"key":"S1092852900006933_ref029","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)80095-4"},{"key":"S1092852900006933_ref089","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.49.4.290"},{"key":"S1092852900006933_ref066","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.2.120"},{"key":"S1092852900006933_ref027","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.142.2.174"},{"key":"S1092852900006933_ref061","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1176\/ajp.152.9.1368","article-title":"Sertraline for social phobia: a double-blind, placebo-controlled crossover study","volume":"152","author":"Katzelnick","year":"1995","journal-title":"Am J Psychiatry"},{"key":"S1092852900006933_ref101","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199804000-00005"},{"key":"S1092852900006933_ref113","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200012000-00009"},{"key":"S1092852900006933_ref064","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.8.708"},{"key":"S1092852900006933_ref013","volume-title":"The International Classification of Diseases","year":"1992"},{"key":"S1092852900006933_ref046","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-000-0082-7"},{"key":"S1092852900006933_ref119","doi-asserted-by":"publisher","DOI":"10.1037\/10348-006"},{"key":"S1092852900006933_ref110","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199308000-00004"},{"key":"S1092852900006933_ref084","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199606003-00014"},{"key":"S1092852900006933_ref069","doi-asserted-by":"crossref","unstructured":"Liebowitz MR , DeMartinis N , Weihs KL , Chung H , Fayyad R , Clary CM . Results from a randomized, double-blind, multicenter trial of sertraline in the treatment of moderate-to-severe social phobia (social anxiety disorder). Poster presented at: 40th Annual Meeting of the American College of Neuropsychopharmacology; December 9\u201313, 2001; Waikaloa, Hawaii.","DOI":"10.1016\/S0924-977X(02)80559-4"},{"key":"S1092852900006933_ref052","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(91)90055-W"},{"key":"S1092852900006933_ref018","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199606003-00016"},{"key":"S1092852900006933_ref037","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1980"},{"key":"S1092852900006933_ref074","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(01)00236-6"},{"key":"S1092852900006933_ref105","first-page":"S283","article-title":"Mirtazapine in social anxiety disorder","volume":"3","author":"van Vliet","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"S1092852900006933_ref015","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199710006-00003"},{"key":"S1092852900006933_ref096","first-page":"123","article-title":"Phenelzine and atenolol in social phobia","volume":"26","author":"Liebowitz","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"S1092852900006933_ref115","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(99)80414-3"},{"key":"S1092852900006933_ref011","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199710006-00004"},{"key":"S1092852900006933_ref075","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00182-1"},{"key":"S1092852900006933_ref073","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014302"},{"key":"S1092852900006933_ref005","first-page":"47","article-title":"Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety","volume":"62","author":"Ballenger","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref103","doi-asserted-by":"publisher","DOI":"10.1002\/1520-6394(2000)12:1+<90::AID-DA13>3.0.CO;2-B"},{"key":"S1092852900006933_ref006","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830020077009"},{"key":"S1092852900006933_ref007","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1176\/ajp.151.3.408","article-title":"Setting diagnostic thresholds for social phobia: considerations from a community survey of social anxiety","volume":"151","author":"Stein","year":"1994","journal-title":"Am J Psychiatry"},{"key":"S1092852900006933_ref008","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-995294"},{"key":"S1092852900006933_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)80094-2"},{"key":"S1092852900006933_ref078","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1203"},{"key":"S1092852900006933_ref012","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"S1092852900006933_ref014","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810180011002"},{"key":"S1092852900006933_ref016","first-page":"54","article-title":"Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety","volume":"59","author":"Ballenger","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00140-8"},{"key":"S1092852900006933_ref019","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199606003-00004"},{"key":"S1092852900006933_ref020","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1016\/S0924-977X(99)80416-7","article-title":"Disability associated with social anxiety disorder","volume":"9","author":"Wittchen","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"S1092852900006933_ref049","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(99)80049-2"},{"key":"S1092852900006933_ref021","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820040034004"},{"key":"S1092852900006933_ref022","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.5.613"},{"key":"S1092852900006933_ref109","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0405"},{"key":"S1092852900006933_ref097","first-page":"35","article-title":"Clonazepam in the treatment of social phobia: a pilot study","volume":"51","author":"Munjack","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-6185(02)00134-2"},{"key":"S1092852900006933_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(95)00066-6"},{"key":"S1092852900006933_ref025","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198808000-00011"},{"key":"S1092852900006933_ref030","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199211000-00015"},{"key":"S1092852900006933_ref031","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-6185(97)00004-2"},{"key":"S1092852900006933_ref071","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244762"},{"key":"S1092852900006933_ref032","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199101000-00005"},{"key":"S1092852900006933_ref033","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00092-5"},{"key":"S1092852900006933_ref034","first-page":"2244","article-title":"Coming face-to-face with social phobia","volume":"60","author":"Stein","year":"1999","journal-title":"Am Fam Physician"},{"key":"S1092852900006933_ref036","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291797005928"},{"key":"S1092852900006933_ref038","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(00)00213-3"},{"key":"S1092852900006933_ref040","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(99)80018-2"},{"key":"S1092852900006933_ref043","unstructured":"Katzelnick DJ , Kobak KA , Helstad CP , et al. The direct and indirect costs of social phobia in managed care patients. Paper presented at: 19th Annual Conference of the Anxiety Disorders Association of America; March 1999; San Diego, Calif."},{"key":"S1092852900006933_ref047","first-page":"4","article-title":"Brain mechanisms of social anxiety disorder","volume":"59","author":"Nutt","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref048","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(99)00109-8"},{"key":"S1092852900006933_ref051","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1176\/ajp.147.5.637","article-title":"Major depression in patients with social phobia","volume":"147","author":"Stein","year":"1990","journal-title":"Am J Psychiatry"},{"key":"S1092852900006933_ref053","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00089-5"},{"key":"S1092852900006933_ref054","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)80014-0"},{"key":"S1092852900006933_ref055","first-page":"S284","article-title":"Cigarette smoking and anxiety disorders","volume":"3","author":"Nascimento","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"S1092852900006933_ref056","first-page":"141","volume-title":"Modern Problems of Pharmacopsychiatry: Anxiety","author":"Liebowitz","year":"1987"},{"key":"S1092852900006933_ref062","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v57n1103"},{"key":"S1092852900006933_ref059","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(79)90041-X"},{"key":"S1092852900006933_ref045","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.9.10.2215"},{"key":"S1092852900006933_ref060","volume-title":"Praxis Post","author":"Cattalani","year":"2001"},{"key":"S1092852900006933_ref063","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199606000-00005"},{"key":"S1092852900006933_ref083","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.172.1.70"},{"key":"S1092852900006933_ref065","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1999.tb10845.x"},{"key":"S1092852900006933_ref067","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(2000)11:3<99::AID-DA3>3.0.CO;2-Z"},{"key":"S1092852900006933_ref068","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.2.275"},{"key":"S1092852900006933_ref072","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/ajp.156.5.756","article-title":"Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study","volume":"156","author":"Stein","year":"1999","journal-title":"Am J Psychiatry"},{"key":"S1092852900006933_ref076","first-page":"27","article-title":"Fluoxetine efficacy in social phobia","volume":"54","author":"van Ameringen","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"S1092852900006933_ref080","doi-asserted-by":"publisher","DOI":"10.1007\/BF02900196"},{"key":"S1092852900006933_ref085","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1980"},{"key":"S1092852900006933_ref086","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(92)90032-4"},{"key":"S1092852900006933_ref087","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1995.tb09596.x"},{"key":"S1092852900006933_ref088","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.12.1133"},{"key":"S1092852900006933_ref090","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198808000-00008"},{"key":"S1092852900006933_ref082","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199708000-00002"},{"key":"S1092852900006933_ref104","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0205"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852900006933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T12:50:16Z","timestamp":1692449416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852900006933\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":127,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S1092852900006933"],"URL":"https:\/\/doi.org\/10.1017\/s1092852900006933","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}